Sign in
225 - High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL
Journal article   Open access  Peer reviewed

225 - High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL

Mazyar Shadman, Cecilia CS Yeung, Mary Redman, Sang Yun Lee, Dong Hoon Lee, Susan Ra, Chaitra S Ujjani, Bruce J Dezube, Christina Poh, Edus H. Warren, …
Transplantation and cellular therapy, Vol.28(3), pp.S182-S183
2022-03
url
https://doi.org/10.1016/S2666-6367(22)00386-4View
Published (Version of record) Open

Metrics

1 Record Views

Details